| Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in Cancer |
Advanced Science |
2025-05 |
OMIX001073
More
|
Secondary use |
| Hypoxia‐based critical gene biomarkers as prognostic reporters for gastric adenocarcinoma |
Environmental Toxicology |
2023-12 |
OMIX001073
More
|
Secondary use |
| FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity |
Cancer Letters |
2025-01 |
OMIX001073
More
|
Secondary use |
| Multi-omics analysis reveals the heterogeneity and interactions among stromal and tumor cells in gastric cancer |
Translational Oncology |
2026-01 |
OMIX001073
More
|
Secondary use |
| scRNA-seq of gastric tumor shows complex intercellular interaction with an alternative T cell exhaustion trajectory |
Nature Communications |
2022-08 |
OMIX001073
More
|
Deposit |
| Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors |
Nature Communications |
2025-05 |
OMIX001073
More
|
Secondary use |
| Nociceptive neurons promote gastric tumour progression via a CGRP–RAMP1 axis |
Nature |
2025-02 |
OMIX001073
More
|
Secondary use |
| Multi-omics analysis identifies diagnostic circulating biomarkers and potential therapeutic targets, revealing IQGAP1 as an oncogene in gastric cancer |
npj Precision Oncology |
2025-04 |
OMIX001073
More
|
Secondary use |
| Nociceptive neurons interact directly with gastric cancer cells via a CGRP/Ramp1 axis to promote tumor progression |
bioRxiv |
2024-03 |
OMIX001073
More
|
Secondary use |
| Sketching T cell atlases in the single‐cell era: challenges and recommendations |
Immunology and Cell Biology |
2025-06 |
OMIX001073
More
|
Secondary use |
| Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment |
Journal for Immunotherapy of Cancer |
2023-11 |
OMIX001073
More
|
Secondary use |
| Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer |
Journal for Immunotherapy of Cancer |
2025-03 |
OMIX001073
More
|
Secondary use |
| Mutual exclusivity and co-occurrence patterns of immune checkpoints indicate NKG2A relates to anti-PD-1 resistance in gastric cancer |
Journal of Translational Medicine |
2024-08 |
OMIX001073
More
|
Secondary use |
| Re-analysis of single cell and spatial transcriptomics data reveals B cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis |
Journal of Translational Medicine |
2024-08 |
OMIX001073
More
|
Secondary use |
| C3+ cancer-associated fibroblasts promote tumor growth and therapeutic resistance in gastric cancer via activation of the NF-κB signaling pathway |
Journal of Translational Medicine |
2024-12 |
OMIX001073
More
|
Secondary use |
| ESRP1 exerts anti-tumor role by promoting ferroptosis in diffuse-type gastric cancer |
Journal of Experimental & Clinical Cancer Research |
2025-06 |
OMIX001073
More
|
Secondary use |
| Integrative analysis of single-cell and bulk RNA sequencing reveals the oncogenic role of ANXA5 in gastric cancer and its association with drug resistance |
Frontiers in Immunology |
2025-03 |
OMIX001073
More
|
Secondary use |
| Transcriptional profiling reveals H.pylori -associated genes induced inflammatory cell infiltration and chemoresistance in gastric cancer |
Frontiers in Immunology |
2025-05 |
OMIX001073
More
|
Secondary use |